Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 149 | $48,829,182 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 27 Apr 2023 | Sale | 197 | 193.18 | 38,056 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 93 | 201.3 | 18,721 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 955 | 200.35 | 191,334 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 385 | 199.54 | 76,823 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 715 | 198.03 | 141,591 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 103 | 196.62 | 20,252 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 204 | 195.46 | 39,874 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 129 | 197.08 | 25,423 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 80 | 195.65 | 15,652 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 779 | 194.94 | 151,858 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 700 | 193.93 | 135,751 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 151 | 193.18 | 29,170 | D |
10 Apr 2023 16:29 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 06 Apr 2023 | Sale | 3,500 | 210 | 735,000 | D |
07 Mar 2023 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 03 Mar 2023 | Sale | 18,072 | 200 | 3,614,400 | D |
14 Feb 2023 16:03 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 10 Feb 2023 | Sale | 4,302 | 217.05 | 933,749 | D |
14 Feb 2023 16:03 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 10 Feb 2023 | Sale | 19,447 | 216.38 | 4,207,942 | D |
14 Feb 2023 16:03 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 10 Feb 2023 | Sale | 10,279 | 215.59 | 2,216,050 | D |
14 Feb 2023 16:03 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 10 Feb 2023 | Sale | 2,307 | 214.28 | 494,344 | D |
14 Feb 2023 16:03 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 10 Feb 2023 | Sale | 1,709 | 213.13 | 364,239 | D |
03 Feb 2023 17:46 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 02 Feb 2023 | Sale | 5 | 227.38 | 1,137 | D |
03 Feb 2023 17:46 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 02 Feb 2023 | Sale | 586 | 226.62 | 132,799 | D |
03 Feb 2023 17:46 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 02 Feb 2023 | Sale | 1,007 | 225.8 | 227,381 | D |
03 Feb 2023 17:46 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 02 Feb 2023 | Sale | 77 | 223.97 | 17,246 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 953 | 233.31 | 222,344 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 1,293 | 232.53 | 300,661 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 865 | 231.35 | 200,118 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 185 | 230.2 | 42,587 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 128 | 227.68 | 29,143 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 4 | 227.38 | 910 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 561 | 226.62 | 127,134 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 963 | 225.8 | 217,445 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 73 | 223.97 | 16,350 | D |
23 Nov 2022 16:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | AUSIELLO DENNIS A | Director | 21 Nov 2022 | Sale | 22,500 | 220 | 4,950,000 | D |
17 Aug 2022 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 15 Aug 2022 | Sale | 715 | 232.81 | 166,459 | D |
17 Aug 2022 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 15 Aug 2022 | Sale | 3,853 | 231.65 | 892,547 | D |
17 Aug 2022 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 15 Aug 2022 | Sale | 16,186 | 230.71 | 3,734,272 | D |
17 Aug 2022 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 15 Aug 2022 | Sale | 11,600 | 229.93 | 2,667,188 | D |
17 Aug 2022 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 15 Aug 2022 | Sale | 1,218 | 228.33 | 278,106 | D |
17 Aug 2022 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 15 Aug 2022 | Sale | 98 | 226.16 | 22,164 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 104 | 225.15 | 23,416 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 5 | 224 | 1,120 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 105 | 220.95 | 23,200 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 99 | 219.53 | 21,733 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 541 | 218.71 | 118,322 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 440 | 217.61 | 95,748 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 398 | 216.21 | 86,052 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 149 | 215.03 | 32,039 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Aug 2022 | Sale | 1,754 | 210 | 368,340 | D |
07 Jul 2022 16:06 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Jul 2022 | Sale | 1,754 | 150 | 263,100 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)